Medical University of South Carolina: Research to Revenue

Medical University of South Carolina

Summit Venture Studio

Research to Revenue Report

Summit Venture Studio (SVS) Opportunities

SVS has identified 4 commercialization opportunities from Medical University of South Carolina and scored them based on our proprietary metrics and rubrics.

The SVS model is to identify the top 1% of commercialization opportunities and start companies around them.

Please connect with SVS if you would like to engage with us in our startup and investment efforts.

Return on Research (ROR) Analysis

Commercialization Revenue per Research Dollar

Top Universities by Return on Research (ROR)

ROI Ratio: Commercialization Revenue ÷ Research Funding

University Innovation Analysis

Total Innovation Scores by Institution

Top Universities by Innovation Score

180+ High Innovation

150-179 Strong Innovation

130-149 Moderate Innovation

100-129 Emerging Innovation

130+ total score considered high innovation impact

SVS Innovation Index

Proprietary Assessment of Medical University of South Carolina's Innovation Ecosystem
Score out of 100. Benchmark: Top 50 U.S. research institutions.
A score of 90/100 can be read "doing better than 90% of schools benchmarked"

Innovation Visibility

70/100

Definition: Media mentions, publication count, and global research visibility metrics

Startup Momentum

7/100

Definition: Growth in patents, funding, and startup formation

Ecosystem Strength

36/100

Definition: Tech transfer infrastructure and support systems

Innovation Legacy

A Timeline of Groundbreaking Discoveries

Innovation Timeline

Founded

1824

First Nobel

N/A

First Patent

1977

First IPO

N/A

2022-2024

AI-driven diagnostics

2025

Today

Notable Commercialization Outcomes

Nobel Prizes

1980s

First Patent

Patent for medical device

1980s

Spin-off Founded

Company from cancer research

1995

License Agreement

Biotech drug licensed out

2005

Research Collaboration

Partnered with pharma industry

2010

Innovation Award

Recognized for tech transfer

2018

Competitive Benchmarking

Medical University of South Carolina vs. Peer Research Universities

Medical University of South Carolina vs Peers Comparison

Metric	Medical University of South Carolina (FY2023)	Peer Average	Elite Average
Annual R&D Expenditure	$334M	$855M	$1,675M
New Inventions Disclosed	2	200	400
Startups Formed	1	7	10
Visibility Index	12	12	23
Licensing Revenue	$2M	$17M	$46M

Note: Peer Average = Median value among U.S. R1 research universities. Elite Average = Top 10 ranked U.S. research universities.

Emerging Opportunities

1. AI-Driven Diagnostics Revolutionizing Early Disease Detection

Advanced AI algorithms enable faster, accurate diagnoses, reducing healthcare costs and improving patient outcomes in a rapidly growing global diagnostics market.

2. Novel Cancer Immunotherapy Enhancing Treatment Efficacy

Innovative immunotherapy targets resistant tumors, offering scalable, personalized cancer treatments addressing unmet needs in oncology with significant market potential.

3. Biodegradable Drug Delivery Systems for Targeted Therapy

Sustainable, controlled-release drug carriers improve treatment precision and reduce side effects, addressing rising demand in pharmaceutical and biotech industries.

4. Wearable Health Monitoring Devices Empowering Chronic Care

Real-time biometric tracking technology supports proactive disease management, tapping into the expanding remote health monitoring market with scalable applications.

5. Regenerative Medicine Using Stem Cell Technologies

Cutting-edge stem cell therapies promote tissue repair and organ regeneration, addressing chronic disease burdens with high-growth potential in regenerative medicine.

6. Digital Health Platforms Integrating Patient Data Analytics

Comprehensive data platforms enhance clinical decision-making and patient engagement, capitalizing on the booming digital health market’s demand for scalable solutions.